Citurgia Biochemicals Limited accepted the resignation of Yatendra Kumar from the post of Company Secretary and Compliance Officer effective July 24, 2026. The departure follows his decision to pursue career opportunities outside the company.

The Mumbai-based chemical manufacturer filed additional details with the Bombay Stock Exchange on September 8, 2026, under Regulation 30 of the SEBI (LODR) Regulations, 2015. This filing served to rectify an inadvertent omission in the initial intimation dated July 24, 2026.

Regulatory Compliance and Oversight

The company disclosed that while the resignation was intimated within the prescribed timeline, the actual resignation letter was not attached due to an unintentional error during the initial filing process. Citurgia submitted the missing document as Annexure-2 in the subsequent communication.

Kashi Nath, Whole Time Director, signed the clarification letter, expressing regret for the lapse. He assured the exchange that due care will be taken in future disclosures to ensure complete compliance with applicable regulations.

Key Details of Resignation

The resignation of a Key Managerial Personnel requires timely disclosure to stock exchanges. The delayed submission of the supporting document highlights a procedural gap, though the company has since regularized the record.

Krebs Biochemicals & Industries reported a narrowed net loss of ₹248.48 lakh for the first quarter ended June 30, 2026, marking an improvement from the ₹532.43 lakh loss recorded in the corresponding period of FY25. The company’s standalone revenue from operations rose 30% year-on-year to ₹714 lakh, up from ₹549.26 lakh in Q1FY26, indicating modest top-line growth amid ongoing profitability challenges.

The Board of Directors approved the unaudited financial results on August 6, 2026, in compliance with Regulation 30 and Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were published in Business Standard and Prajasakti on August 7, 2026, and filed with BSE Limited and the National Stock Exchange of India Ltd.

Financial Performance Overview

The net loss before tax stood at ₹248.48 lakh for the quarter, compared to ₹532.43 lakh in Q1FY26. This reduction in losses coincided with the 30% increase in operational revenue. However, the company continues to report negative earnings per share, with basic EPS at ₹(1.15) versus ₹(2.47) in the previous year’s quarter.

What the Numbers Show

The divergence between revenue growth and persistent losses suggests that cost structures or input prices may still be exerting pressure on margins. While top-line expansion is evident, the bottom line has not yet turned positive. The total comprehensive income for the period remained at ₹(248.48) lakh, identical to the net loss after tax, indicating no significant other comprehensive income items offsetting the operational deficit.

Regulatory and Compliance Details

The financial results were prepared in accordance with Indian Accounting Standards (Ind AS) as prescribed under the Companies (Indian Accounting Standards) Rules, 2015, as amended by the 2016 Amendment Rules. The full format of the quarterly results is available on the company’s website and the stock exchange portals. Manish Kumar Jain, Managing Director, signed off on the results dated August 6, 2026, from Mumbai.